Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank13
3Y CAGR-47.3%
5Y CAGR-28.6%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-47.3%/yr
vs +11.4%/yr prior
5Y CAGR
-28.6%/yr
Recent deceleration
Acceleration
-58.8pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.67% |
| Q3 2025 | 4.88% |
| Q2 2025 | 3.43% |
| Q1 2025 | 1.24% |
| Q4 2024 | 0.28% |
| Q3 2024 | 3.97% |
| Q2 2024 | 4.21% |
| Q1 2024 | 2.76% |
| Q4 2023 | 4.00% |
| Q3 2023 | 4.37% |
| Q2 2023 | 2.32% |
| Q1 2023 | 3.57% |
| Q4 2022 | 11.45% |
| Q3 2022 | 4.73% |
| Q2 2022 | 3.03% |
| Q1 2022 | -0.34% |
| Q4 2021 | 8.75% |
| Q3 2021 | 12.80% |
| Q2 2021 | 32.92% |
| Q1 2021 | 3.62% |
| Q4 2020 | 8.99% |
| Q3 2020 | 16.14% |
| Q2 2020 | -21.65% |
| Q1 2020 | 8.72% |
| Q4 2019 | 5.48% |
| Q3 2019 | 8.05% |
| Q2 2019 | 4.11% |
| Q1 2019 | 7.14% |
| Q4 2018 | 11.58% |
| Q3 2018 | 8.89% |
| Q2 2018 | 9.90% |
| Q1 2018 | 7.80% |
| Q4 2017 | 2.48% |
| Q3 2017 | 8.80% |
| Q2 2017 | 12.49% |
| Q1 2017 | 10.02% |
| Q4 2016 | -0.36% |
| Q3 2016 | 9.83% |
| Q2 2016 | 6.49% |
| Q1 2016 | 4.19% |